Overturn Myriad Genetics patent on the gene sequences of BRCA1 and BRCA2
This petition had 251 supporters
Myriad Genetics retains a monopoly on the *sequencing* of these genes, and as a result has made it cost-prohibitive for many American women to get these genes sequenced. This has inhumanely and unconstitutionally increased the breast and ovarian cancer burdens on women without the means to pay for the gene sequencing in question.
Today: J is counting on you
J Humphreys needs your help with “U.S. Supreme Court: Overturn Myriad Genetics patent on the gene sequences of BRCA1 and BRCA2”. Join J and 250 supporters today.